Caliway Received U.S. FDA Fast Track Designation for CBL-514 for the Treatment of Dercum's Disease
/PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the...